Education
About Us
Working with TipRanks
Follow Us
Sanofi SA (SNY)
:SNY
Total Valuation
Sanofi has a market cap or net worth of $126.22B. The enterprise value is ―.
Market Cap$126.22B
Enterprise Value―
Share Statistics
Sanofi has 2,454,938,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,454,938,000
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 10.99%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)10.99%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee534.35K
Profits Per Employee66.31K
Employee Count82,878
Asset Turnover0.33
Inventory Turnover1.40
Valuation Ratios
The current PE Ratio of Sanofi is 12.8. Sanofi’s PEG ratio is 11.30.
PE Ratio12.8
PS Ratio2.63
PB Ratio1.50
Price to Fair Value1.50
Price to FCF19.80
Price to Operating Cash Flow8.18
PEG Ratio11.30
Income Statement
In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 2.19.
Revenue44.29B
Gross Profit31.09B
Operating Income14.45B
Pretax Income6.76B
Net Income5.56B
EBITDA11.66B
Earnings Per Share (EPS)2.19
Cash Flow
In the last 12 months, operating cash flow was 2.09B and capital expenditures 0.00, giving a free cash flow of 2.09B billion.
Operating Cash Flow2.09B
Free Cash Flow2.09B
Free Cash Flow per Share0.85
Dividends & Yields
Sanofi pays an annual dividend of $2.212, resulting in a dividend yield of 4.3%
Dividend Per Share$2.212
Dividend Yield4.3%
Payout Ratio54.35%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change-1.46%
50-Day Moving Average48.69
200-Day Moving Average50.34
Relative Strength Index (RSI)62.17
Average Volume (3m)3.60M
Important Dates
Sanofi upcoming earnings date is Jan 29, 2026, Before Open (Confirmed).
Last Earnings DateOct 24, 2025
Next Earnings DateJan 29, 2026
Ex-Dividend DateMay 09, 2025
Financial Position
Sanofi as a current ratio of 1.46, with Debt / Equity ratio of 31.83%
Current Ratio1.46
Quick Ratio1.14
Debt to Market Cap0.14
Net Debt to EBITDA0.95
Interest Coverage Ratio19.29
Taxes
In the past 12 months, Sanofi has paid 1.20B in taxes.
Income Tax1.20B
Effective Tax Rate0.18
Enterprise Valuation
Sanofi EV to EBITDA ratio is 11.51, with an EV/FCF ratio of 21.58.
EV to Sales2.87
EV to EBITDA11.51
EV to Free Cash Flow21.58
EV to Operating Cash Flow13.99
Balance Sheet
Sanofi has $15.36B in cash and marketable securities with $22.29B in debt, giving a net cash position of -$6.93B billion.
Cash & Marketable Securities$15.36B
Total Debt$22.29B
Net Cash-$6.93B
Net Cash Per Share-$2.82
Tangible Book Value Per Share$4.73
Margins
Gross margin is 71.63%, with operating margin of 32.63%, and net profit margin of 12.55%.
Gross Margin71.63%
Operating Margin32.63%
Pretax Margin15.26%
Net Profit Margin12.55%
EBITDA Margin24.91%
EBIT Margin16.82%
Analyst Forecast
The average price target for Sanofi is $62.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$62.50
Price Target Upside25.68% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-9.32%
EPS Growth Forecast120.62%